Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
昌海生物的生物工程项目进展顺利
Read online
昌海生物的生物工程项目进展顺利
8月12日,浙江医药股份有限公司 昌海生物分公司(昌海生物)表示,公司的昌海生物工程项目建设进展顺利。据企业介绍,年产100吨高含量维生素E技改项目已经建成投产;其年产5000万瓶(袋)乳酸左氧氟沙星大容量注射剂制剂项目预计2015年12月之前能完成施工建设。 昌海生物工程项目建设主要包括生命营养类产品、制剂出口基地、原料药等三大类22个子项目,预计总投资29.12亿元。从2014年开始实施,预计在2018年全面建成。其中主要的维生素类产品包括维生素E、维生素A、维生素D3以及生物素。
Vitamins China E-News 201508 (Chinese version)
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...